Partial Characterization of a Novel Growth Factor from the Blood of Women with Preeclampsia*
- 1 May 1990
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 70 (5) , 1285-1291
- https://doi.org/10.1210/jcem-70-5-1285
Abstract
Sera obtained before delivery from women with preeclampsia contain greater mitogenic activity than sera drawn from the same women 24–48 h after parturition or sera from normal parturients. These studies describe the initial characterization of the blood-borne mitogenic factor(s) from preeclamptic women which we have named ELMER (Endogenous Ligand conferring MitogEnic Response). ELMER appears to be a unique mitogen with characteristics that are not identical to those of other known growth factors. ELMER is present in serum as an acid- and heat-labile protein, approximately 160,000 daltons in size, which is a potent mitogen for human fibroblasts but not for human endothelial cells. Its presence in plasma suggests that it is a circulating factor rather than a product of blood coagulation ex vivo. We believe that ELMER represents a potential serum marker of preeclampsia and that it may play roles in the vasospasm and proliferative vascular lesion, termed atherosis, frequently associated with the preeclamptic syndrome.Keywords
This publication has 0 references indexed in Scilit: